PATENT CLAIM ANALYSIS

Application Number: 16116080
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-05
Patent Classification: ["530", "313000"]

Abstract:
This invention provides long-acting, superactive analogs of glycoprotein hormones demonstrating enhanced bioactivity both in vitro and in vivo as compared to wild type counterparts. The analogs are particularly useful for treating subjects showing low receptor expression or poor receptor responsiveness, and for the treatment of any condition associated with glycoprotein hormone activity.

Claim (Index 7):
The modified human FSH of  claim 4 , comprising the amino acid substitutions T11R, Q13R, E14R, P16R, and Q20R.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 96.0
- Lexical Diversity: 1.19149
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13954690', '15034670', '14309317', '12028155', '13187956']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7231638347137341
- 35 USC 102 Novelty (BERT): 0.6355583394826445
- Combined Prediction Score: 0.7144032851906252
- Mean Citation Score: 547.8927580000002
- Max Citation Score: 700.7843
- Similarity Product: 529.5952210295558

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test